Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,395 | 27,733 | 47,129 | 13,954 | 17,080 |
| Marketable Securities | 83,247 | N/A | N/A | N/A | 0 |
| Receivables | 234,085 | 209,282 | 194,400 | 182,242 | 193,890 |
| Inventories | 190,258 | 166,372 | 139,179 | 132,519 | 126,270 |
| Income taxes - deferred | 31,056 | 37,052 | 27,537 | 20,770 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 41,470 |
| TOTAL | $655,398 | $466,614 | $430,828 | $369,668 | $378,710 |
| Non-Current Assets | |||||
| PPE Net | 179,123 | 142,235 | 132,974 | 119,032 | 125,940 |
| Investments And Advances | 0 | 0 | 0 | 0 | 1,160 |
| Intangibles | 81,754 | 69,519 | 77,703 | 90,970 | 0 |
| Other Non-Current Assets | 76,321 | 42,335 | 42,523 | 66,608 | 163,030 |
| TOTAL | $337,198 | $254,089 | $253,200 | $276,610 | $290,130 |
| Total Assets | $992,596 | $720,703 | $684,028 | $646,278 | $668,860 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 208 | 760 | 5,720 | 11,656 | 10,410 |
| Accounts payable and accrued liabilities | 53,995 | 50,233 | 64,903 | 62,965 | 64,730 |
| Accrued Expenses | 71,650 | 62,800 | 58,434 | 52,354 | 74,000 |
| Other current liabilities | 48,183 | 71,392 | 47,205 | 47,430 | 41,810 |
| TOTAL | $239,252 | $208,930 | $199,106 | $189,308 | $202,520 |
| Non-Current Liabilities | |||||
| Long Term Debt | 225,835 | 105,768 | 188,423 | 203,360 | 239,210 |
| aiOther Non-Current Liabilities | 16,899 | 13,079 | 0 | 0 | 0 |
| TOTAL | $257,537 | $128,686 | $201,045 | $212,352 | $246,220 |
| Total Liabilities | $496,789 | $337,616 | $400,151 | $401,660 | $448,740 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,650 | 25,295 | 24,974 | N/A | N/A |
| Common Shares | 3 | 3 | 2 | 2 | 12,460 |
| Retained earnings | 421,012 | 344,841 | 276,554 | 231,821 | 200,990 |
| Other shareholders' equity | 32,628 | 2,102 | -22,850 | -13,801 | -5,170 |
| TOTAL | $495,807 | $383,087 | $283,877 | $244,618 | $220,110 |
| Total Liabilities And Equity | $992,596 | $720,703 | $684,028 | $646,278 | $668,850 |